Form 8-K - Current report:
SEC Accession No. 0001193125-20-026812
Filing Date
2020-02-06
Accepted
2020-02-06 16:30:10
Documents
12
Period of Report
2020-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d852725d8k.htm   iXBRL 8-K 21805
  Complete submission text file 0001193125-20-026812.txt   140160

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pgen-20200131.xsd EX-101.SCH 3093
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgen-20200131_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgen-20200131_pre.xml EX-101.PRE 10968
11 EXTRACTED XBRL INSTANCE DOCUMENT d852725d8k_htm.xml XML 3222
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 20583075
SIC: 8731 Services-Commercial Physical & Biological Research